REFUSAL OF EXAMINATION

This adverse event was reported 131 times

These drugs are most commonly taken by patients reporting REFUSAL OF EXAMINATION:

# Drug Count
0 CLOZAPINE 83
1 OLANZAPINE 30
2 QUETIAPINE 29
3 RISPERIDONE 29
4 ARIPIPRAZOLE 27
5 ARIPIPRAZOLE ORAL 26
6 ARIPIPRAZOLE ORALLY DISINTEGRATING 26
7 AMISULPRIDE 25
8 HALOPERIDOL 21
9 HALOPERIDOL LACTATE 21
See all common drugs associated with REFUSAL OF EXAMINATION

REFUSAL OF EXAMINATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMISULPRIDE 25 0.0041
1 FLUPHENAZINE DECANOATE 1 0.0023
2 DATOPOTAMAB DERUXTECAN 1 0.0012
3 OXAPROZIN 1 0.0011
4 HALOPERIDOL LACTATE 21 0.0008
5 CLOZAPINE 83 0.0007
6 HALOPERIDOL DECANOATE 1 0.0006
7 OLANZAPINE 30 0.0004
8 SULINDAC 1 0.0004
9 RISPERIDONE 29 0.0004
See all drugs enriched for association with REFUSAL OF EXAMINATION

REFUSAL OF EXAMINATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dopamine-2 Receptor Antagonist [EPC] 25 0.0032
1 Typical Antipsychotic [EPC] 21 0.0008
2 Monobactam Antibacterial [EPC] 1 0.0004
3 Atypical Antipsychotic [EPC] 89 0.0002
4 Sulfone [EPC] 1 0.0001
5 Nitrofuran Antibacterial [EPC] 1 0.0001
6 Protease Inhibitor [EPC] 2 0.0000
7 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
8 Tetracycline-class Drug [EPC] 2 0.0000
9 Thiazide-like Diuretic [EPC] 1 0.0000
See all drug classes enriched for association with REFUSAL OF EXAMINATION